Severe Nephrotic Syndrome Secondary to Primary Membranous Nephropathy in an Adult
DOI:
https://doi.org/10.70409/rmhhut.v19i2.171Keywords:
anti-PLA2R antibodies, renal biopsy, primary membranous nephropathy, nephrotic syndrome, proteinuriaAbstract
Introduction: Primary membranous nephropathy is one of the leading causes of nephrotic syndrome in adults and represents a diagnostic challenge due to the need to exclude multiple secondary etiologies. Presentation of case: We report the case of a 39-year-old man who presented with anasarca, oliguria, and exertional dyspnea associated with massive proteinuria (23.8 g/24 h) and severe hypoalbuminemia. Given the complexity of the presentation, an extensive diagnostic workup was performed to rule out autoimmune diseases, malignancies, amyloidosis, and monoclonal gammopathies through immunological testing, biopsies, and immunohistochemical studies. Renal biopsy confirmed membranous nephropathy, and subsequent detection of anti-PLA2R antibodies established its primary origin. The patient initially received the modified Ponticelli regimen; however, disease activity persisted, leading to the initiation of rituximab as second-line therapy. Conclusion: This case highlights the importance of differential diagnosis and etiological confirmation in the management of primary membranous nephropathy.
References
. Efe O, So PNH, Anandh U, Lerma EV, Wiegley N. An updated review of membranous nephropathy. Indian J Nephrol. 2024;34(2):105-118. doi:10.25259/IJN_356_2023.
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Mayo Clin Proc. 2023;98(10):1671-1684. doi:10.1016/j.mayocp.2023.05.024.
Goggins E, DeLaat A, Barr B, Taliercio J, Mehdi A, Nakhoul G, et al. Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts. J Nephrol. 2025;38(7):1889-1900. doi:10.1007/s40620-025-02313-6.
Torres ZG, Ortega-Salas R. Patología estructural en enfermedades glomerulares primarias. Actual Med. 2024;109:176-186.
Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983-997. doi:10.2215/CJN.11761116.
Glomerulonefritis primarias [Internet]. Nefrología al Día [citado 2026 Jun 4]. Disponible en: https://nefrologiaaldia.org/es-articulo-glomerulonefritis-primarias-545
Teisseyre M, Cremoni M, Boyer-Suavet S, Ruetsch C, Graça D, Esnault VLM, Brglez V, Seitz-Polski B. Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy. Front Immunol. 2022;13:859419. doi:10.3389/fimmu.2022.859419.
Blanco Pardo M, Rodríguez Magariños C, Sierra Castro D. Nefropatía membranosa primaria [Internet]. Nefrología al Día. 2022 [citado 2026 Jun 4]. Disponible en: https://www.nefrologiaaldia.org/es-articulo-nefropatia-membrosa-primaria-489
Mansur A. Membranous nephropathy [Internet]. Medscape. 2025 [citado 2026 Jun 4]. Disponible en: https://emedicine.medscape.com/article/239799-overview
Alsharhan L, Beck LH Jr. Membranous nephropathy: Core Curriculum 2021. Am J Kidney Dis. 2021;77(3):440-453. doi:10.1053/j.ajkd.2020.10.009.
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


